The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ashrafian L.A.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr rentgenoradiologii" Minzdrava RF, Moskva

Kiselev V.I.

Acad. V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia

Kuznetsov I.N.

Moscow State University of Medicine and Dentistry Named After A.I. Evdokimov

Muizhnek E.L.

Russian X-ray Radiology Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Gerfanova E.V.

Russian X-ray Radiology Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Vashakmadze S.L.

Russian X-ray Radiology Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Molecular cancer biology and prospects for effective therapy

Authors:

Ashrafian L.A., Kiselev V.I., Kuznetsov I.N., Muizhnek E.L., Gerfanova E.V., Vashakmadze S.L.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2016;5(3): 80‑87

DOI: 10.17116/onkolog20165280-87

Read: 3246 times

Download PDF (RU)
Contact the author
Table of contents

MOLECULAR CANCER BIOLOGY AND PROSPECTS FOR EFFECTIVE THERAPY
MOLECULAR CANCER BIOLOGY AND PROSPECTS FOR EFFECTIVE THERAPY

To cite this article:

Ashrafian LA, Kiselev VI, Kuznetsov IN, Muizhnek EL, Gerfanova EV, Vashakmadze SL. Molecular cancer biology and prospects for effective therapy. P.A. Herzen Journal of Oncology. 2016;5(3):80‑87. (In Russ.)
https://doi.org/10.17116/onkolog20165280-87

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Meta­static meni­ngiomas: a case series and lite­rature review. Burdenko's Journal of Neurosurgery. 2025;(3):83-91
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Comparative analysis of morphometric and histological characteristics of HPV-associated and HPV-independent vulvar squamous cell carcinoma. Russian Journal of Archive of Pathology. 2025;(3):26-32
Surgical treatment of giant meta­static myxoid lipo­sarcoma of the peri­cardium. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):363-365
The role of DNA methylation, histone modi­fications, and non-coding RNA expression in the pathogenesis of premature ovarian insu­fficiency and inno­vative ways to overcome infe­rtility from the point of epigenetic disturbances. Russian Journal of Human Reproduction. 2025;(3):6-19
Expe­rimental and clinical evaluation of the safety and effi­cacy of Poly­dexa spray with phenylephrine in acute rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2025;(4):39-46
The role of Inflasinusans in the treatment of acute rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2025;(4):64-71
Use of ozone therapy in the treatment of complications following pene­trating kera­toplasty for rosa­cea-associated kera­titis. Russian Annals of Ophthalmology. 2025;(4):66-72
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411
The use of grape poly­phenols in combination with magnetic therapy in patients with bronchial asthma who have suffered a new coro­navirus infe­ction. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(4):14-19
Abstract:

Due to recent fundamental discoveries, the concept of carcinogenesis, the development of metastatic disease, the patterns of a recurrent malignant process, and the mechanisms involved in the development of resistance has undergone considerable changes. The pooled currently accumulated information allow one to confidently assert that cancer progresses due to the emergence of clones owing to oncogene mutations or epigenetic modifications recorded in the stem cells. The understanding of dormancy, which has become accessible in oncology, the disclosure of its mechanisms, and the role of the inflammatory microenvironment must make a considerable contribution to the development of effective systemic therapy.

Keywords:

carcinogenesis
metastasis
metastatic niche
dormancy
cancer stem cells
inflammation
tumor growth rate model
epigenetics
antitumor therapy

Authors:

Ashrafian L.A.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr rentgenoradiologii" Minzdrava RF, Moskva

Kiselev V.I.

Acad. V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia

Kuznetsov I.N.

Moscow State University of Medicine and Dentistry Named After A.I. Evdokimov

Muizhnek E.L.

Russian X-ray Radiology Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Gerfanova E.V.

Russian X-ray Radiology Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Vashakmadze S.L.

Russian X-ray Radiology Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

Close metadata

References:

  1. Napalkov N, Tserkovnyi G, Merabishvili V. Malignant tumors in the USSR [Zlokachestvennye novoobrazovaniya v SSSR]. Leningrad; 1980. (In Russ.)
  2. Chissov V, Remennik L, ed. Malignant tumors in Russia in the 1980—1995 [Zlokachestvennye novoobrazovaniya v Rossii v 1980—1995]. Moscow: RANKO-Press; 1998. (In Russ.)
  3. Chissov V, Starinskii V, Petrova G, eds. Malignant tumors in Russia in the 2010 (morbidity and mortality) [Zlokachestvennye novoobrazovaniya v Rossii v 2010 (zabolevaemost' i smertnost')]. Moscow: FGBU «MNIOI im. P.A. Gertsena» Minzdravsotsrazvitiya Rossii; 2012. (In Russ.)
  4. Lyu T, Jia N, Wang J, Yan X, Yu Y, Lu Z et al. Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of carcinoma. Epigenetics. 2013;8(12):1330-1346. doi:10.4161/epi.26675.
  5. Chen H, Hardy TM, Tollefsbol TO. Epigenomics of ovarian cancer and its chemoprevention. Front Genet. 2011;2:67.  doi:10.3389/fgene.2011.00067.
  6. Ashrafyan L, Kiselev V. Modern oncology, molecular biology and prospects of effective therapy [Sovremennaya onkologiya, molekulyarnaya biologiya i perspektivy effektivnoi terapii]. Moscow: Molodaya gvardiya; 2015. (In Russ.)
  7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100(7):3983-3988. doi:10.1073/pnas.0530291100.
  8. Dick JE. Breast cancer stem cells revealed. Proc Natl Acad Sci USA. 2003;100:3547-3549. doi:10.1073/pnas.0830967100.
  9. Marx J. Cancer research. Mutan stem cells may seed cancer. Science. 2003;301(5638):1308-1310. doi:10.1126/science.301.5638.1308.
  10. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3:895-902.  doi:10.1038/nrc1232.
  11. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396-401.  doi:10.1038/nature03128.
  12. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea — a paradigm shift. Cancer Res. 2006;66:1883-1890, discussion 1895-1896. doi:10.1158/0008-5472.can-05-3153.
  13. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23(43):7274-7282. doi:10.1038/sj.onc.1207947.
  14. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: The origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer. 2005;5(11):899-904.  doi:10.1038/nrc1740.
  15. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105-111.  doi:10.1038/35102167.
  16. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2(8):563-572.  doi:10.1038/nrc865.
  17. Fidler IJ. 7th Jan Waldenström Lecture. The biology of human cancer metastasis. Acta Oncol. 1991;30(6):668-675.  doi:10.3109/02841869109092438.
  18. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4(6):448-456.  doi:10.1038/nrc1370.
  19. Cameron MD, Schmidt EE, Kerkvliet N et al. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 2000;60(9):2541-2546.
  20. Chambers AF, MacDonald IC, Schmidt EE, Morris VL, Groom AC. Clinical targets for anti-metastasis therapy. Adv Cancer Res. 2000;79:91-121.  doi:10.1016/s0065-230x(00)79003-8.
  21. Chambers AF, Naumov GN, Varghese HJ, Nadkarni KV, MacDonald IC, Groom AC. Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am. 2001;10(2):243-55,vii.
  22. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, ChambersA F, Groom AC. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998;153(3):865-873.
  23. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559-1564. doi:10.1126/science.1203543.
  24. Wittekind C, Neid M. Cancer invasion and metastasis. Oncology. 2005;69(Suppl.1):14-16.  doi:10.1159/000086626.
  25. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 2006;66(9):4553-4557. doi:10.1158/0008-5472.can-05-3986.
  26. MacDonald IC, Groom AC, Chambers AF. Cancer spread and micrometastasis development: Quantitative approaches for in vivo models. BioEssays. 2002;24(10):885-893.  doi:10.1002/bies.10156.
  27. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1(2):149-153.  doi:10.1038/nm0295-149.
  28. Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy. APMIS. 2008;116(7-8):754-770.  doi:10.1111/j.1600-0463.2008.01033.x.
  29. Cristofanilli M. The «microscopic» revolution in breast carcinoma. Cancer. 2005;103(5):877-880.  doi:10.1002/cncr.20838.
  30. Lugo TG, Braun S, Cote RJ et al. Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol. 2003;21(13):2609-2615. doi:10.1200/jco.2003.01.153.
  31. Meng S, Tripathy D, Frenkel EP et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004;10(24):8152-8162. doi:10.1158/1078-0432.ccr-04-1110.
  32. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst. 1999;91(13):1113-1124. doi:10.1093/jnci/91.13.1113.
  33. Araujo RP, McElwain DLS. A history of the study of solid tumour growth: the contributionof mathematical modeling. Bull Math Biol. 2004;66(5):1039-1091. doi:10.1016/j.bulm.2003.11.002.
  34. Kolobov A, Gubernov V, Polezhaev A. Fisher type waves in a model of invasive tumor growth. Matematicheskoe modelirovanie. 2007;19(6):31-42. (In Russ.)
  35. Swanson KR, Bridge C, Murray JD, Alvord EC Jr. Virtual and real brain tumors: using mathematical modeling to quantify glioma growth. J Neurol Sci. 2003;216(1):1-10.  doi:10.1016/j.jns.2003.06.001.
  36. Karrison TG, Ferguson DJ, Meier P. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst. 1999;91(1):80-85.  doi:10.1093/jnci/91.1.80.
  37. Paez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, Ning Y et al. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res. 2012;18(3):645-653.  doi:10.1158/1078-0432.ccr-11-2186.
  38. Röcken M. Early tumor dissemination, but late metastasis:insights into tumor dormancy. J Clin Invest. 2010;120(6):1800-182.  doi:10.1172/jci43424.
  39. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431-436.  doi:10.1038/nature04870.
  40. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-444.  doi:10.1038/nature07205.
  41. Nickoloff BJ, Ben-Neriah Y, Pikarsky E. Inflammation and cancer: is the link as simple as we think? J Invest Dermatol. 2005;124(6):x—xiv.  doi:10.1111/j.0022-202x.2005.23724.x.
  42. Demicheli R, Retsky MW, Hruchetsky WJ, Baum M. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: leaning from failures. Nat Clin Pract Oncol. 2007;4(12):699-710.  doi:10.1038/ncponc0999.
  43. Retsky M, Demicheli R, Hrushesky W, Forget P, Kock M, Gukas I et al. Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review. Curr Med Chem. 2013;20(33):4163-4176. doi:10.2174/09298673113209990250.
  44. Kim MK, Kim K, Han JY, Lim JM, Song YS. Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer. Genes Nutr. 2011;6(2):109-115.  doi:10.1007/s12263-011-0209-y.
  45. Li Y, Wicha MS, Schwartz SJ, Sun D. Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J Nutr Biochem. 2011;22(9):799-806.  doi:10.1016/j.jnutbio.2010.11.001.
  46. Kandala PK, Srivastava SK. DIMming ovarian cancer growth. Curr Drug Targets. 2012;13(14):1869-1875. doi:10.2174/138945012804545650.
  47. Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 2008;269(2):269-280.  doi:10.1016/j.canlet.2008.04.014.
  48. Hong CB, Kim ÍÀ, Firestone GL et al. 3,3’-Diindolyl-methane (DIM) induces aG(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis (Lond). 2002;23:1297-1305. doi:10.1093/carcin/23.8.1297.
  49. Kim YS, Milner JA. Targets for indole-3-carbinol in cancer prevention. J Nutr Biochem. 2005;16(2):65-73.  doi:10.1016/j.jnutbio.2004.10.007.
  50. Ashrafyan L, Kiselev V, Muizhnek E, Antonova I, Kuznetsov I, Aleshikova O, Gerfanova E. Ovarian cancer: the concept of pathogenesis and principles of treatment. Onkologiya. Zhurnal im. P.A. Gertsena. 2015;4(3):73-81. (In Russ.)
  51. Ashrafyan L, Kiselev V, Muizhnek E, Gerfanova E, Antonova I, Kuznetsov I, Aleshikova O. Current principles of effective therapy for ovarian cancer. Opukholi zhenskoi reproduktivnoi sistemy. 2015;11(2):68-75. (In Russ.) doi:10.17650/1994-4098-2015-11-2-68-75.
  52. Ashrafyan LA, Antonova IB, Aleshikova OI. Indole-3-carbinol and Epigallatcatechin-3-gallate in combination therapy of ovarian cancer. Int J Gynecol Cancer. 2015;25(Suppl.2):432.
  53. Ashrafyan L, Antonova I, Aleshikova O, Dobrovol'skaya N, Chazova N. Complex ultrasound diagnostic assessment of the results of neoadjuvant chemotherapy for locally advanced cervical cancer (Stages IIB—IIIB). Opukholi zhenskoi reproduktivnoi sistemy. 2007;4:63-71. (In Russ.)
  54. Ashrafyan L, Antonova I, Ivashina S, Babaeva N, Myagkova A, Aleshikova O, Lyustik A. Molecular biological and ultrasonic methods in evaluating the effectiveness of drug therapy in patients with cervix cancer and ovarian cancer. Opukholi zhenskoi reproduktivnoi sistemy. 2012;3-4:120-125. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.